ATA508673A - Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen - Google Patents

Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen

Info

Publication number
ATA508673A
ATA508673A AT508673A AT508673A ATA508673A AT A508673 A ATA508673 A AT A508673A AT 508673 A AT508673 A AT 508673A AT 508673 A AT508673 A AT 508673A AT A508673 A ATA508673 A AT A508673A
Authority
AT
Austria
Prior art keywords
quaternar
pyridines
oxides
preparation
pyridinium salts
Prior art date
Application number
AT508673A
Other languages
English (en)
Other versions
AT333277B (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA508673A publication Critical patent/ATA508673A/de
Application granted granted Critical
Publication of AT333277B publication Critical patent/AT333277B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT508673A 1972-06-14 1973-06-08 Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen AT333277B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26289872A 1972-06-14 1972-06-14
BE147896A BE819177R (fr) 1972-06-14 1974-08-26 Oxazolo- et thiazolopyridines

Publications (2)

Publication Number Publication Date
ATA508673A true ATA508673A (de) 1976-03-15
AT333277B AT333277B (de) 1976-11-10

Family

ID=25648082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT508673A AT333277B (de) 1972-06-14 1973-06-08 Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen

Country Status (17)

Country Link
JP (1) JPS5943475B2 (de)
AR (1) AR208500A1 (de)
AT (1) AT333277B (de)
AU (1) AU472528B2 (de)
BE (2) BE800868A (de)
CA (1) CA1019741A (de)
CS (1) CS178889B2 (de)
DD (1) DD105237A5 (de)
DE (1) DE2330109A1 (de)
DK (1) DK152050C (de)
FI (1) FI57417C (de)
FR (1) FR2187356B1 (de)
GB (1) GB1421619A (de)
LU (1) LU67786A1 (de)
NL (1) NL184836C (de)
SE (2) SE401675B (de)
ZA (1) ZA733760B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527321A1 (de) * 1975-06-19 1976-12-23 Merck & Co Inc Oxazol eckige klammer auf 4,5-b eckige klammer zu pyridine
JPS527992A (en) * 1975-07-04 1977-01-21 Merck & Co Inc Oxazolo *4*55b* pyridines
NL187021C (nl) * 1975-07-15 1991-05-01 Merck & Co Inc Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte anti-inflammatoir werkzame 2-fenyl-oxazolo-(4,5-b)pyridinederivaten.
US4011326A (en) * 1975-07-29 1977-03-08 Merck & Co., Inc. 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents
US4753673A (en) * 1977-07-22 1988-06-28 The Dow Chemical Company Trifluoromethyl pyridinyloxyphenoxy and pyridinylthiophenoxy propanoic acids and propanols and derivatives thereof and methods of herbicidal use
DE2862491D1 (en) * 1977-08-12 1988-05-05 Ici Plc Trihalomethylpyridine compounds
JPS5461182A (en) * 1977-10-20 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-phenoxy-5-trifluoromethylpyridine compounds
JPS5461183A (en) * 1977-10-21 1979-05-17 Ishihara Sangyo Kaisha Ltd 2-substituted-5-trifluoromethyl pyridine compounds
DE2967674D1 (en) * 1978-02-15 1988-03-10 Ici Plc Herbicidal derivatives of 2-(4(2-pyridyloxy)phenoxy)propane, processes for preparing them, and herbicidal compositions containing them
JPS55130840U (de) * 1979-03-12 1980-09-16
JPS55124763A (en) * 1979-03-19 1980-09-26 Ishihara Sangyo Kaisha Ltd 5-trifluoromethyl-2-pyridone derivative
GB8333514D0 (en) * 1983-12-16 1984-01-25 Erba Farmitalia Tetrahydrothiazolo(5 4-c)pyridine derivatives
FR2652085A1 (fr) * 1989-09-20 1991-03-22 Science Organisation Nouveau procede de synthese de derives d'oxazolopyridines.
PT937075E (pt) * 1996-11-11 2004-05-31 Altana Pharma Ag Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
BR9910864A (pt) * 1998-06-04 2002-02-05 Abbott Lab Compostos anti-inflamatórios para inibição de aderência celular
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
WO2000075145A1 (en) * 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
AU2002216649A1 (en) * 2000-10-31 2002-05-15 Lynn Bonham Benzoxazole lpaat- beta inhibitors and uses thereof
EP1909910A1 (de) * 2005-08-04 2008-04-16 Sirtris Pharmaceuticals, Inc. Benzimidazol-derivative als sirtuin-modulatoren
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
CL2008001822A1 (es) 2007-06-20 2009-03-13 Sirtris Pharmaceuticals Inc Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
CN102164598A (zh) * 2008-08-29 2011-08-24 特温蒂斯公司 用作神经系统疾病的诊断工具和治疗的丁酰胆碱酯酶配体
CN102388054B (zh) 2008-12-19 2015-03-04 西特里斯药业公司 噻唑并吡啶沉默调节蛋白调节剂的化合物
BR112012007237A2 (pt) * 2009-09-30 2019-09-24 Sumitomo Chemical Co composição e método para controlar pragas artrópodes
CA2812087A1 (en) * 2010-09-15 2012-03-22 F. Hoffmann-La Roche Ag Azabenzothiazole compounds, compositions and methods of use
EP3006429B1 (de) * 2010-12-24 2019-02-06 Sumitomo Chemical Co., Ltd. Kondensierte heterocyclische verbindung und verwendung zur bekämpfung von schädlingen dafür
US20170217941A1 (en) * 2014-06-25 2017-08-03 Epizyme, Inc. Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
CN107207529A (zh) 2014-12-02 2017-09-26 拜耳作物科学股份公司 作为害虫防治剂的双环化合物
US10399966B2 (en) 2016-01-21 2019-09-03 University Of Washington Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
JP7430486B2 (ja) * 2016-07-07 2024-02-13 保土谷化学工業株式会社 ベンゾアゾール環構造を有する化合物および有機エレクトロルミネッセンス素子

Also Published As

Publication number Publication date
DD105237A5 (de) 1974-04-12
LU67786A1 (de) 1973-08-16
GB1421619A (en) 1976-01-21
DE2330109A1 (de) 1974-01-03
FI57417C (fi) 1980-08-11
SE401675B (sv) 1978-05-22
DK152050C (da) 1988-07-18
AT333277B (de) 1976-11-10
JPS4961195A (de) 1974-06-13
NL184836B (nl) 1989-06-16
ZA733760B (en) 1975-01-29
NL7307582A (de) 1973-12-18
JPS5943475B2 (ja) 1984-10-22
SE7604385L (sv) 1976-04-14
NL184836C (nl) 1989-11-16
AR208500A1 (es) 1977-02-15
BE819177R (fr) 1975-02-26
AU472528B2 (en) 1976-05-27
BE800868A (fr) 1973-12-13
AU5651173A (en) 1974-12-05
DK152050B (da) 1988-01-25
FR2187356B1 (de) 1977-01-28
FR2187356A1 (de) 1974-01-18
CA1019741A (en) 1977-10-25
CS178889B2 (en) 1977-10-31
FI57417B (fi) 1980-04-30
SE432767B (sv) 1984-04-16

Similar Documents

Publication Publication Date Title
AT333277B (de) Verfahren zur herstellung von neuen oxazolpyridinen und deren n-oxiden und quaternaren pyridiniumsalzen
AT351557B (de) Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1- phenoxypropanen und von deren saeureadditions- salzen
ATA288275A (de) Verfahren zur herstellung neuer pyridinderivate und ihrer n-oxide und salze
AT339301B (de) Verfahren zur herstellung von neuen pyridinderivaten und deren saureadditionssalzen
AT315842B (de) Verfahren zur Herstellung von neuen 2-Hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoäthyl)-pyridinen und von deren Säureadditionssalzen
AT330175B (de) Verfahren zur herstellung von neuen dihydropyridinpolyestern und deren salzen
AT326657B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen
ATA993673A (de) Verfahren zur herstellung von neuen alfa-aminoacylcephalosporinathern und deren salzen
AT327915B (de) Verfahren zur herstellung von neuen piperazinderivaten und von deren salzen
AT329558B (de) Verfahren zur hersstellung von neuen 2-(2-pyridyl)-omega-phenylalkylaminen und deren saureadditionssalzen
AT327167B (de) Verfahren zur herstellung von neuen 1-aminomethyl-2,2-diarylcyclopropancarbonsaureamiden und deren saureadditionssalzen und quaternaren salzen
AT327923B (de) Verfahren zur herstellung von neuen chinazolindion-verbindungen und deren salzen
ATA687073A (de) Verfahren zur herstellung von neuen 4- (beta-ureidoathyl) benzolsulfonylharnstoffen und deren salzen
AT321296B (de) Verfahren zur Herstellung von neuen Oxazolen und deren Salze
AT329058B (de) Verfahren zur herstellung von neuen aminoimidazoloisochinolinderivaten und deren salzen
AT321907B (de) Verfahren zur herstellung von neuen oxazolidinen und deren salzen
AT321303B (de) Verfahren zur Herstellung von neuen 2-Benzoyl-3-amino-pyridin-Verbindungen und deren Salzen
AT330174B (de) Verfahren zur herstellung neuer piperidin-derivate und von deren salzen
AT332396B (de) Verfahren zur herstellung von neuen m-dioxan-5-methylaminen und von deren salzen
AT327907B (de) Verfahren zur herstellung von neuen 1,4-athano-2,3-dihydrochinolinderivaten und deren salzen
AT320648B (de) Verfahren zur Herstellung von neuen Pyridinderivaten und von deren Salzen
AT320649B (de) Verfahren zur Herstellung von neuen 2-Benzoyl-3-aminopyridin-Verbindungen und deren Salzen
ATA764775A (de) Verfahren zur herstellung von neuen 2-(2-pyridyl)-omega-phenylalkylaminen und deren saureadditionssalzen
AT323167B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren säureadditionssalzen
AT321315B (de) Verfahren zur Herstellung von neuen Ureidophenoxypropylaminderivaten und von deren Salzen